Neoplasm of uncertain behavior of left renal pelvis
ICD-10 D41.12 is a billable code used to indicate a diagnosis of neoplasm of uncertain behavior of left renal pelvis.
A neoplasm of uncertain behavior of the left renal pelvis refers to a growth or tumor located in the renal pelvis of the left kidney that does not exhibit definitive characteristics of malignancy or benignity. These neoplasms can arise from various cell types and may present with nonspecific symptoms such as hematuria (blood in urine), flank pain, or urinary obstruction. The classification as 'uncertain behavior' indicates that the tumor's potential for progression or malignancy is not clearly defined, necessitating careful monitoring and evaluation. Surveillance strategies often include imaging studies such as ultrasound, CT scans, or MRI to assess changes in size or characteristics over time. The management of these neoplasms may involve a multidisciplinary approach, including urologists and oncologists, to determine the best course of action, which may range from active surveillance to surgical intervention depending on the tumor's behavior and patient factors.
Detailed imaging reports, pathology findings, and treatment plans must be documented.
Patients presenting with hematuria or flank pain, requiring imaging to evaluate for renal masses.
Urologists must ensure that all findings are clearly documented to support the diagnosis of neoplasm of uncertain behavior.
Comprehensive treatment plans, including surveillance protocols and any interventions performed.
Patients with a known renal mass requiring oncological assessment for potential malignancy.
Oncologists should document the rationale for surveillance versus intervention to justify coding.
Used when a biopsy is performed to determine the nature of the neoplasm.
Pathology report must be included in the patient's medical record.
Urologists and oncologists should ensure that the pathology findings are clearly documented.
It refers to a tumor that cannot be definitively classified as benign or malignant, requiring careful monitoring and evaluation.
